Rising adoption of automated and AI-enabled synthesis platforms positions pharmaceutical and biotechnology companies for ...
FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other diabetes medications in their adverse ...
The most common side effects of GLP-1 medicines are related to digestion: nausea, vomiting, diarrhoea, indigestion, stomach ...
The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat ...
Analysis has found a link between semaglutide use and suicidal thoughts but not all evidence supports these findings ...
Easier to take, just as effective and far cheaper than fat jab rivals such as Ozempic and Mounjaro, a promising new pill is ...
The WHO’s announcement came hours after Australia released a safety alert over the potential risk of suicidal thoughts and behaviours for people using the medicines.
The rise of GLP-1 receptor agonists, including Ozempic and Mounjaro, being used for weight loss has been linked to a higher ...
Australia's drugs regulator has issued a fresh warning for users of high-profile injectable diabetes and weight-loss drugs such as Ozempic.
Alarming reports have surfaced after the national medicines watchdog disclosed information linking users of popular weight ...
AAP Newsroom on MSN
Mental health warning issued for weight-loss drugs
The Australian medicines regulator has issued a mental health safety warning for a drug widely used for weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback